Armata Pharmaceuticals, Inc.
AMEX:ARMP · New York Stock Exchange American
+$0.11 today
Vol 0.15M · Avg 0.06M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+265.05%
Period High
$14.80
Period Low
$1.84
Latest
$6.79
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
SELLAS Life Sciences Group, Inc.
NASDAQ:SLS
$1.12B
Genfit S.A.
GNFT
$445.68M
C4 Therapeutics, Inc.
NASDAQ:CCCC
$323.03M
Nuvectis Pharma, Inc.
NASDAQ:NVCT
$284.09M
OmniAb, Inc.
NASDAQ:OABI
$270.34M
Codexis, Inc.
NASDAQ:CDXS
$218.15M
Innate Pharma S.A.
NASDAQ:IPHA
$165.27M
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX
$150.58M
Neonc Technologies Holdings, Inc.
NASDAQ:NTHI
$94.98M
Sangamo Therapeutics, Inc.
NASDAQ:SGMO
$62.14M
What is the latest ARMP filing?
The latest filing shown is SC 13D/A dated May 13, 2026.
How many recent filings does ARMP have?
Intrinsic Alpha currently shows 20 recent filings for ARMP.
Explore More
Continue the stock analysis
Jump to another research area for this company.